Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04176848
Title CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Canadian Cancer Trials Group
Age Groups: adult | senior
Covered Countries CAN

No variant requirements are available.